Business Description
Cocrystal Pharma is a US-based drug development company working to create new treatments for serious viral infections, including influenza, norovirus, coronaviruses, and hepatitis C. The company uses advanced structural biology methods to design its medicines, with several candidates currently in clinical trials. It works alongside partners such as Merck and Kansas State University to advance its research pipeline.
